Testosterone Treatment Options
The majority of patients with low testosterone levels exhibit reduced sexual drive, altered mood and unexplained lethargy and fatigue.
As discussed earlier (Background of Testosterone use in females) injections of testosterone and testosterone implants have largely been superseded by products designed for delivering physiological doses of testosterone appropriate for use in women. These products are:
AndroFeme® 1% testosterone cream (Lawley Pharmaceuticals, Australia)
Intrinsa® transdermal testosterone patch (Proctor and Gamble, USA)
AndroFeme® 1% testosterone cream
(Lawley Pharmaceuticals, Australia).
AndroFeme® 1% testosterone cream has been available in Australia since 1998 and is currently the only available approved testosterone product available for delivering testosterone safely and effectively to women. AndroFeme® is applied topically to the inner thighs, arms or lower abdomen once daily. The dose is titratable and the usual dose is 1-2cm (5-10mg testosterone) daily (measurer included). Cost is USD$50 for a 6-12 weeks supply.
To order AndroFeme® click here.
For AndroFeme® Product Information details click here. PDF
For AndroFeme® Consumer Medication Information click here. PDF
For further information on AndroFeme® testosterone cream click here.
Intrinsa® testosterone patch
(Proctor and Gamble, USA).
The testosterone patch is yet to be approved by the USA Food and Drug Administration (FDA) or the Australian Therapeutic Goods Administration (TGA). Intrinsa has been approved by the European Agency for the Evaluation of Medicinal Products (EMEA), but is yet to be released onto the USA or Australian market. Cost in the UK is around £100 (€145 USD$190) for a 1 month supply.